New Drugs

Brand/Generic Company Description
Avsola
infliximab
Amgen

Biosimilar to Remicade.

Beovu
brolucizumab
Novartis

Intravitreal VEGF inhibitor for neovascular (wet) age-related macular degeneration.

Cablivi
caplacizumab
Sanofi Genzyme

An injectable antithrombotic for acquired thrombotic thrombocytopenic purpura.

Kanjinti
trastuzumab
Amgen

Biosimilar to Herceptin.

Mayzent
siponimod
Novartis

An oral sphingosine 1-phosphate receptor modulator for multiple sclerosis.

Nubeqa
darolutamide
Bayer

An oral antiandrogen for non-metastatic castration resistant prostate cancer.

Osnuvo
teriparatide
Avir Pharma

A biosimilar to Forteo.

Piqray
alpelisib
Novartis

Oral kinase inhibitor for advanced/metastatic breast cancer.

Rozlytrek
entrectinib
Hoffmann-La Roche

A tyrosine kinase inhibitor for advanced extracranial solid tumours, including brain metastases.

Vyndaqel
tafamidis meglumine
Pfizer

An oral transthyretin stabilizer for cardiomyopathy due to transthyretin-mediated amyloidosis.

Xofluza
baloxavir marboxil
Hoffmann-La Roche

An oral antiviral for treating influenza.

Brand/Generic Company Description
Peyona
caffeine citrate
Chiesi (Spain)

CNS stimulant for primary apnea in premature newborns.

Suvexx
sumatriptan/naproxen
Nuvo Pharm.

New oral triptan/NSAID combination for acute migraine.

Brand/Generic Company Description